Thermo Fisher Scientific to offer integrated COVID-19 testing to school districts nationwide
The program was developed in partnership with Color Health, Inc., a California-based leader in distributed healthcare services
The program was developed in partnership with Color Health, Inc., a California-based leader in distributed healthcare services
Dr. Simon Bates’ addition supports continued focus on innovation, development, and customer experience for X-ray analysis
Enhanced insights with unhindered access to high curated quality data combined with advanced visual analytics and data automation
This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant
The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools
A response to the unprecedented global demand for key scientific resources
Just share a photo of your current incubator to enter the competition
By consolidating up to four analytical units on a single platform, testing efficiency in high-volume labs is increased
Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by four days
Therapy used for the treatment of certain patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinoma
Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
This partnership aims to offer an accelerated route to market rapid test technologies
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
The company is set to support the $12 billion expansion in COVID-19 testing as vaccinations increase